Moderna stock crashes after leaked cancer vaccine trial data
Statements (10 of 20)
- Bearish
Moderna's stock fell 18% after a data breach revealed details of its experimental cancer vaccine.
- Bearish
Moderna's mRNA cancer vaccine trial data was leaked to social media platforms
- Bearish
Moderna shares tanked after research data was leaked
- Bearish
Moderna shares plunged following the release of leaked data on a cancer vaccine.
- Bearish
Moderna shares sink after leaked cancer data missed expectations
- Bearish
Moderna stock price fell 17.57% after reports of a possible data leak regarding a melanoma vaccine.
- Bearish
Moderna shares fell 18% after leaked trial results for its melanoma vaccine showed smaller risk reduction than earlier studies.
- Bearish
Moderna stock crashes due to leaked melanoma data threatening its record August rally
- Bearish
Moderna and Merck stocks fell after data on the melanoma vaccine was leaked.
- Bearish
Moderna stock price fell 24% after unverified leaks about its melanoma vaccine
10 more statements on this development this week. The API returns all of them: GET /v2/statements?topic_id=e5e233fc-7fcd-456e-a9a7-24b4f81398f3 Get a free API key ↗